Page 1

Exact Sciences announces third quarter 2021 results EXACT SCIENCES NEWS PROVIDED BY Exact Sciences Corporation → Nov 02 , 2021 , 16:05 ET MADISON , Wis . , Nov. 2 , 2021 / PRNewswire / -- Exact Sciences Corp. ( Nasdaq : EXAS ) today announced that the company generated revenue of $ 456.4 million for the third quarter ended September 30 , 2021 , compared to $ 408.4 million for the same period of 2020 . " Exact Sciences is entering an exciting period for its pipeline , generating evidence to support innovative tests that will help defeat cancer through earlier detection , " said Kevin Conroy , chairman and CEO . " Our powerful commercial engine will help us achieve our mission by getting more people tested with Cologuard® , Oncotype DXⓇ , and our future tests . " Third quarter 2021 financial results For the three - month period ended September 30 , 2021 , as compared to the same period of 2020 ( where applicable ) : до